Authors
Loading...
Systematic investigation identifies key genes and miRNAs driving lung adenocarcinoma, suggesting potential biomarkers.
Navaei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: